##analysisDate=2017-06-28-14-13-49000
##analyzedBy=RingStudy Site E
##exportDate=2017-11-08-12-57-11000
##analysisName=Sample 9-PHASE1
##workflowName=Oncomine Focus w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site E-R1-Sample 9-F-D_v1:Site E-R5-Sample 9-F-R_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=842
##filterInCount=26
##filteredOutCount=816
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:11184624	A/C	A	SNV		MTOR	exonic	1								26.82	p.Val2198Gly		1995	A=0.7318, C=0.2682		Present				-	47	NM_004958.3	c.6593T>G	missense	2.23	0.01	109.0	1.0	FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction	Everolimus,Pimecrolimus,Sirolimus,Temsirolimus		0.00001	2498.83	A=1460, C=535		A=809/651, C=291/244	1	
chr1:11188179	AG/AGG	AG	INDEL		MTOR	exonic	1								A=0.00, AGG=9.55	p.Leu1972fs		1990	AG=0.9045, A=0.0, AGG=0.0955		Present				-	43	NM_004958.3	c.5914_5915insC	frameshiftInsertion	2.21,0.74				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction	Everolimus,Pimecrolimus,Sirolimus,Temsirolimus		0.00006	42.0341	AG=1800, A=0, AGG=190		AG=697/1103, A=0/0, AGG=80/110	3,3	
chr1:65310489	T/C	T	SNV		JAK1	exonic	1								31.19	p.(=)		1805	T=0.6323, C=0.3677		Present				-	16	NM_002227.2	c.2199A>G	synonymous	-4.13				Protein kinase domain,Protein tyrosine kinase	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	5071.13	T=968, C=563		T=720/248, C=389/174	1	
chr1:65310510	G/GC	G	INDEL		JAK1	exonic	1								10.20	p.Ile727fs		1981	G=0.898, GC=0.102		Present				-	16	NM_002227.2	c.2177_2178insG	frameshiftInsertion	2.61				Protein kinase domain,Protein tyrosine kinase								ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00005	42.8812	G=1779, GC=202		G=1037/742, GC=126/76	3	
chr1:156834532, chr1:156851323			ASSAYS_5P_3P		NTRK1								NTRK1.5p.eNST00000392302.e2e3,NTRK1.3p.eNST00000392302.e17e18				0,98				NoCall	3.0E-4		0.0000,2.5980e-10																						0.0					
chr2:29416366	G/C	G	SNV		ALK	exonic	1								48.20	p.Asp1529Glu		2000	G=0.518, C=0.482		Present				-	29	NM_004304.4	c.4587C>G	missense	-1.46	1.0	45.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1881421		0.435 (ref)	0.3438	0.3915	0.4335	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	7233.3	G=1036, C=964		G=461/575, C=462/502	1	
chr2:29416572	C/C	T	SNV		ALK	exonic	1								100.00	p.Ile1461Val		1996	T=0.0, C=1.0		Present				-	29	NM_004304.4	c.4381A>G	missense	-0.25	1.0	29.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1670283		0.007 (ref)	3.0E-4	0.0279	0.0097		ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	26920.6	T=0, C=1996		T=0/0, C=924/1072	1	
chr2:29436938	A/AG	A	INDEL		ALK	exonic	1								10.18	p.Ser1219fs		1975	A=0.8982, AG=0.1018		Present				-	24	NM_004304.4	c.3654_3655insC	frameshiftInsertion	0.4				MAM domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00002	46.9614	A=1774, AG=201		A=883/891, AG=55/146	3	
chr2:29551347, chr2:29430138			ASSAYS_5P_3P		ALK								ALK.5p_NM_004304.4.e5e6,ALK.3p_NM_004304.4.e23e24				39661,5157				Absent, LOW_5P_3P_IMBALANCE_SCORE	-0.1047		1.0514e-07,1.3672e-08																						0.0					
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1988	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	26698.0	G=0, A=1988		G=0/0, A=1205/783	1	
chr4:1808387	G/GC	G	INDEL		FGFR3	exonic	1								22.64	p.Ala717fs		1988	G=0.7736, GC=0.2264		Present				+	16	NM_000142.4	c.2148_2149insC	frameshiftInsertion	2.21				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	711.095	G=1538, GC=450		G=704/834, GC=399/51	3	
chr4:55141055	G/G	A	SNV		PDGFRA	exonic	1								100.00	p.(=)		1994	A=0.0, G=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	-5.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778		0.037 (ref)	0.0015	0.1185	0.0411	YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	26764.4	A=0, G=1994		A=0/0, G=1097/897	1	
chr4:55593625	ATGGAAACAATTATGTTTACATAGACC/ATGGAAACAATTATGTTTACATAGACCC	ATGGAAACAATTATGTTTACATAGACC	INDEL		KIT	exonic	1					HS	COSM22376		ATGGAAACAATTATGTTTACATAGAC=0.00, ATGGAAACAATTATGTTTACATAGACCC=9.42, CCT=0.00	p.Thr574fs		1932	ATGGAAACAATTATGTTTACATAGACC=0.9058, ATGGAAACAATTATGTTTACATAGAC=0.0, ATGGAAACAATTATGTTTACATAGACCC=0.0942, CCT=0.0		Present				+	11	NM_000222.2	c.1718_1719insC	frameshiftInsertion	2.32,0.2,2.88,2.88,-1.23,2.32,1.09,1.58,2.32,2.32,0.54,2.32,2.32,-0.26,2.88,2.32,-0.39,2.32,2.32,0.91,2.32,2.32,0.12,2.88,2.32,2.88,2.88				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs200945282							ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	248.634	ATGGAAACAATTATGTTTACATAGACC=1750, ATGGAAACAATTATGTTTACATAGAC=0, ATGGAAACAATTATGTTTACATAGACCC=182, CCT=0		ATGGAAACAATTATGTTTACATAGACC=745/1005, ATGGAAACAATTATGTTTACATAGAC=0/0, ATGGAAACAATTATGTTTACATAGACCC=173/9, CCT=0/0	3,3,3	
chr4:55593686	T/TC	T	INDEL		KIT	exonic	1								16.04	p.Arg586fs		1995	T=0.8396, TC=0.1604		Present				+	11	NM_000222.2	c.1755_1756insC	frameshiftInsertion	0.2				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	285.393	T=1675, TC=320		T=677/998, TC=269/51	3	
chr5:112175568	G/GC	G	INDEL		APC	exonic	1								12.77	p.Gly1428fs		1981	G=0.8723, GC=0.1277		Present				+	16	NM_000038.5	c.4280_4281insC	frameshiftInsertion	2.88				APC 15 residue motif,APC basic domain,APC cysteine-rich region,Armadillo/beta-catenin-like repeat,EB-1 Binding Domain,SAMP Motif								APC-Axin-1-beta-catenin complex,Axin-APC-beta-catenin-GSK3B complex,T cell differentiation in thymus,anterior/posterior pattern specification,apoptotic process,axis specification,axonal growth cone,axonogenesis,beta-catenin binding,beta-catenin destruction complex,cadherin binding,canonical Wnt receptor signaling pathway,cell adhesion,cell cycle arrest,cell junction,cell migration,cell-cell adherens junction,cellular component disassembly involved in apoptosis,centrosome,chromosome organization,cytokinesis after mitosis,cytoplasm,cytoplasmic microtubule,cytoplasmic microtubule organization,cytoskeleton,cytosol,dorsal/ventral pattern formation,establishment or maintenance of cell polarity,gamma-catenin binding,hair follicle development,kidney development,kinetochore,lamellipodium,lateral plasma membrane,microtubule binding,microtubule plus end,microtubule plus-end binding,mitotic cell cycle spindle assembly checkpoint,mitotic metaphase/anaphase transition,muscle cell homeostasis,negative regulation of MAPKKK cascade,negative regulation of apoptotic process,negative regulation of canonical Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cyclin-dependent protein kinase activity,negative regulation of epithelial cell proliferation involved in prostate gland development,negative regulation of microtubule depolymerization,negative regulation of odontogenesis,neuron projection development,neuronal cell body,nucleus,pancreas development,plasma membrane,positive regulation of apoptotic process,positive regulation of cell adhesion,positive regulation of cell division,positive regulation of cell migration,positive regulation of epithelial cell differentiation,positive regulation of microtubule polymerization,positive regulation of protein catabolic process,positive regulation of pseudopodium assembly,protein binding,protein complex assembly,protein kinase binding,protein kinase regulator activity,proximal/distal pattern formation,regulation of attachment of spindle microtubules to kinetochore,regulation of cell cycle,regulation of microtubule-based process,regulation of nitrogen compound metabolic process,regulation of osteoblast differentiation,regulation of osteoclast differentiation,response to DNA damage stimulus,response to drug,retina development in camera-type eye,ruffle membrane,skin development,somatic stem cell maintenance,synapse,thymus development,tight junction,tight junction assembly			0.00001	139.139	G=1728, GC=253		G=861/867, GC=204/49	3	
chr5:176517985	A/G	A	SNV		FGFR4	exonic	1								42.92	p.(=)		643	A=0.5708, G=0.4292		Present				+	5	NM_213647.1	c.483A>G	synonymous	-3.74				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	1909.36	A=367, G=276		A=216/151, G=268/8	1	
chr7:116339425	T/TC	T	INDEL		MET	exonic	1								11.00	p.Cys98fs		1964	T=0.89, TC=0.11		Present				+	2	NM_001127500.1	c.290_291insC	frameshiftInsertion	0.12				IPT/TIG domain,Plexin repeat,Protein kinase domain,Protein tyrosine kinase,Sema domain	rs371941340			1.0E-4	0.0	1.0E-4		ATP binding,axon guidance,basal plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,hepatocyte growth factor receptor signaling pathway,hepatocyte growth factor-activated receptor activity,integral to membrane,integral to plasma membrane,multicellular organismal development,nucleotide binding,plasma membrane,protein binding,protein tyrosine kinase activity,receptor activity,signal transduction	1-(2-NITROPHENYL)SULFONYL-1H-PYRROLO3,2-BPYRIDINE-6-CARBOXAMIDE,1-(4-fluorophenyl)-N-3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenyl-2-oxo-1,2-dihydropyridine-3-carboxamide,2-(4-fluorophenyl)-N-{3-fluoro-4-(1H-pyrrolo2,3-bpyridin-4-yloxy)phenylcarbamoyl}acetamide,3-(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine,3-3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-ylphenol,6-{6-(1-methyl-1H-pyrazol-4-yl)1,2,4triazolo4,3-bpyridazin-3-ylsulfanyl}quinoline,K-252a,N-(3-chlorophenyl)-N-methyl-2-oxo-3-(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl-2H-indole-5-sulfonamide,N-({4-(2-aminopyridin-4-yl)oxy-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide		0.00001	49.0322	T=1748, TC=216		T=726/1022, TC=173/43	3	
chr7:140453136	ACTG/TCTG	ACTG	SNV		BRAF	exonic	1	Hotspot	Gain-of-function			HS	COSM26504;COSM6137;COSM18443;COSM476;COSM1583011;COSM474;COSM249889;COSM473;COSM1127;COSM1735763		ACTGTAGCTAGACCAAAATCTG=0.00, CCTG=0.00, GCTG=0.00, TCTG=59.80, CGTG=0.00, CTTG=0.00, TGTG=0.00, TTTG=0.00, CTCG=0.00, TTTA=0.00	p.Val600Glu		1990	ACTG=0.402, ACTGTAGCTAGACCAAAATCTG=0.0, CCTG=0.0, GCTG=0.0, TCTG=0.598, CGTG=0.0, CTTG=0.0, TGTG=0.0, TTTG=0.0, CTCG=0.0, TTTA=0.0		Present				-	15	NM_004333.4	c.1799T>A	missense	2.17,2.69,2.17,2.69	0.0	121.0	0.971	C1-like domain,Phorbol esters/diacylglycerol binding domain (C1 domain),Protein kinase domain,Protein tyrosine kinase,Raf-like Ras-binding domain	rs113488022,rs121913227,rs121913374,rs121913375,rs121913377,rs121913378							ATP binding,MAP kinase kinase kinase activity,activation of MAPKK activity,anti-apoptosis,cytoplasm,cytosol,metal ion binding,mitogen-activated protein kinase kinase binding,negative regulation of apoptotic process,negative regulation of neuron apoptosis,nerve growth factor receptor signaling pathway,nucleotide binding,nucleus,organ morphogenesis,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of peptidyl-serine phosphorylation,protein binding,protein heterodimerization activity,protein kinase activity,protein phosphorylation,protein serine/threonine kinase activity,receptor signaling protein activity,response to cAMP,response to peptide hormone stimulus,small GTPase mediated signal transduction,soluble fraction,synaptic transmission,synaptosome	(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime,N-{2,4-difluoro-3-(5-pyridin-3-yl-1H-pyrrolo2,3-bpyridin-3-yl)carbonylphenyl}ethanesulfonamide,N-{3-(5-chloro-1H-pyrrolo2,3-bpyridin-3-yl)carbonyl-2,4-difluorophenyl}propane-1-sulfonamide,Sorafenib	other,pathogenic	0.00001	11690.5	ACTG=800, ACTGTAGCTAGACCAAAATCTG=0, CCTG=0, GCTG=0, TCTG=1190, CGTG=0, CTTG=0, TGTG=0, TTTG=0, CTCG=0, TTTA=0		ACTG=397/403, ACTGTAGCTAGACCAAAATCTG=0/0, CCTG=0/0, GCTG=0/0, TCTG=570/620, CGTG=0/0, CTTG=0/0, TGTG=0/0, TTTG=0/0, CTCG=0/0, TTTA=0/0	1,1,1,1,1,1,1,1,1,1	
chr8:38271504	A/AG	A	INDEL		FGFR1	exonic	1								24.67	p.Ser773fs		1990	A=0.7533, AG=0.2467		Present				-	18	NM_001174067.1	c.2316_2317insC	frameshiftInsertion	1.94				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis	(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984		0.00001	939.568	A=1499, AG=491		A=791/708, AG=67/424	3	
chr9:80412471	G/A	G	SNV		GNAQ	exonic	1								67.58	p.(=)		1576	G=0.3242, A=0.6758		Present				-	4	NM_002072.4	c.570C>T	synonymous	0.81				G-protein alpha subunit								G-protein beta/gamma-subunit complex binding,G-protein coupled receptor binding,G-protein coupled receptor signaling pathway,GTP binding,GTP catabolic process,GTPase activator activity,GTPase activity,activation of adenylate cyclase activity by G-protein signaling pathway,activation of phospholipase C activity,activation of phospholipase C activity by dopamine receptor signaling pathway,behavior,blood coagulation,cytoplasm,developmental pigmentation,embryonic digit morphogenesis,extrinsic to internal side of plasma membrane,forebrain neuron development,glutamate signaling pathway,guanyl nucleotide binding,guanyl-nucleotide exchange factor activity,heart development,heterotrimeric G-protein complex,membrane fraction,metal ion binding,negative regulation of protein kinase activity,neuron remodeling,nucleotide binding,phospholipase C activity,plasma membrane,platelet activation,positive regulation of GTPase activity,post-embryonic development,protein ADP-ribosylation,protein binding,protein stabilization,regulation of action potential,regulation of catenin import into nucleus,regulation of melanocyte differentiation,signal transducer activity,skeletal system development			0.00001	10146.4	G=511, A=1065		G=259/252, A=619/446	1	
chr10:43606730, chr10:43622086			ASSAYS_5P_3P		RET								RET.5p_NM_020975.4.e6e7,RET.3p_NM_020975.4.e18e19				993,1903				Absent, LOW_5P_3P_IMBALANCE_SCORE	0.0028		2.6325e-09,5.0450e-09																						0.0					
chr10:43613843	T/T	G	SNV		RET	exonic	1								100.00	p.(=)		1940	G=0.0, T=1.0		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	26143.2	G=0, T=1940		G=0/0, T=897/1043	1	
chr12:58145430	C/CG	C	INDEL		CDK4	exonic	1					HS	COSM363684;COSM1989836		A=0.00, CG=3.43, T=0.00	p.Arg24fs		1984	C=0.9657, A=0.0, CG=0.0343, T=0.0		Present				-	2	NM_000075.3	c.70_71insC	frameshiftInsertion	2.86				Protein kinase domain,Protein tyrosine kinase	rs104894340							ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,cell cycle,cell division,chromatin,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,membrane,mitotic cell cycle,nuclear membrane,nucleolus,nucleoplasm,nucleotide binding,nucleus,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell cycle,regulation of gene expression,response to drug,signal transduction,transcription factor complex	Flavopiridol,Purvalanol		0.06124	12.1297	C=1916, A=0, CG=68, T=0		C=945/971, A=0/0, CG=21/47, T=0/0	1,3,1	
chr15:66729129	A/AG	A	INDEL		MAP2K1	exonic	1								15.14	p.Glu114fs		1981	A=0.8486, AG=0.1514		Present				+	3	NM_002755.3	c.340_341insG	frameshiftInsertion	-0.37				Protein kinase domain,Protein tyrosine kinase								ATP binding,Golgi apparatus,Golgi inheritance,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras GTPase binding,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,axon part,cell cortex,cell cycle arrest,cell motility,cellular component movement,cellular senescence,chemotaxis,cytoplasm,cytoskeleton,cytosol,dendrite cytoplasm,epidermal growth factor receptor signaling pathway,innate immune response,insulin receptor signaling pathway,keratinocyte differentiation,labyrinthine layer development,melanosome transport,microtubule,mitogen-activated protein kinase kinase kinase binding,mitosis,negative regulation of cell proliferation,negative regulation of homotypic cell-cell adhesion,nerve growth factor receptor signaling pathway,neuron differentiation,neuron projection morphogenesis,nucleotide binding,nucleus,perikaryon,perinuclear region of cytoplasm,placenta blood vessel development,plasma membrane,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of cell differentiation,positive regulation of cell migration,positive regulation of transcription elongation from RNA polymerase II promoter,protein binding,protein kinase activity,protein serine/threonine kinase activity,protein tyrosine kinase activity,receptor signaling protein tyrosine phosphatase activity,regulation of vascular smooth muscle contraction,response to axon injury,response to glucocorticoid stimulus,response to oxidative stress,signal transduction,small GTPase mediated signal transduction,soluble fraction,spindle pole body,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway,vesicle transport along microtubule	(5S)-4,5-difluoro-6-(2-fluoro-4-iodophenyl)imino-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide,2-(2-chloro-4-iodophenyl)amino-N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluorobenzamide,2-(4-ETHYNYL-2-FLUOROPHENYL)AMINO-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE,5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-(2-Fluoro-4-Iodophenyl)AminoBenzamide,K-252a,N-(5-{3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminophenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine,N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminobenzamide		0.00001	217.823	A=1681, AG=300		A=1031/650, AG=43/257	3	
chr17:37881001	T/TG	T	INDEL		ERBB2	exonic	1					HS	COSM26681;COSM12555;COSM303939		TG=4.76, TGGG=0.00, TGGGCTCCCC=0.00, TGTGTGG=0.00	p.Ser779fs		1954	T=0.9524, TG=0.0476, TGGG=0.0, TGGGCTCCCC=0.0, TGTGTGG=0.0		Present				+	20	NM_004448.3	c.2333_2334insG	frameshiftInsertion	2.01				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								ATP binding,ErbB-3 class receptor binding,Hsp90 protein binding,RNA polymerase I core binding,apical plasma membrane,axon guidance,basal plasma membrane,basolateral plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,cytoplasm,endosome membrane,enzyme linked receptor protein signaling pathway,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,estrus,glial cell differentiation,glycoprotein binding,growth factor binding,heart development,identical protein binding,integral to membrane,lateral loop,liver development,mammary gland development,mammary gland involution,membrane raft,microvillus,motor axon guidance,myelination,negative regulation of apoptotic process,negative regulation of immature T cell proliferation in thymus,nervous system development,neuromuscular junction development,nucleotide binding,nucleus,perinuclear region of cytoplasm,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of Ras protein signal transduction,positive regulation of cell adhesion,positive regulation of cell growth,positive regulation of epithelial cell proliferation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of transcription from RNA polymerase I promoter,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,postsynaptic membrane,protein C-terminus binding,protein autophosphorylation,protein binding,protein dimerization activity,protein heterodimerization activity,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of ERK1 and ERK2 cascade,regulation of angiogenesis,regulation of microtubule-based process,regulation of transcription, DNA-dependent,response to axon injury,response to drug,response to progesterone stimulus,signal transduction,skeletal muscle tissue development,sympathetic nervous system development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,ubiquitin protein ligase binding,wound healing	Lapatinib,Trastuzumab		0.00086	30.6381	T=1861, TG=93, TGGG=0, TGGGCTCCCC=0, TGTGTGG=0		T=953/908, TG=13/80, TGGG=0/0, TGGGCTCCCC=0/0, TGTGTGG=0/0	3,3,3,3	
chr17:41276091	A/T	A	SNV		BRCA1	exonic	1								6.91	p.Val8Asp		275	A=0.9309, T=0.0691		Present				-	2	NM_007300.3	c.23T>A	missense	1.62	0.0	152.0	0.999	BRCA1 C Terminus (BRCT) domain,Zinc finger	rs80359887							BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA damage response, signal transduction resulting in induction of apoptosis,DNA recombination,DNA repair,DNA replication,G2/M transition DNA damage checkpoint,RNA binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,brain development,cell cycle,cellular response to indole-3-methanol,centrosome cycle,chordate embryonic development,chromosome segregation,condensed nuclear chromosome,cytoplasm,damaged DNA binding,dosage compensation, by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,enzyme binding,filamentous actin,focal adhesion,gamma-tubulin ring complex,intracellular,ligase activity,metal ion binding,mitochondrial matrix,negative regulation of centriole replication,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K9 methylation,negative regulation of transcription, DNA-dependent,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of cell cycle arrest,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-dependent,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein ubiquitination,regulation of apoptotic process,regulation of cell motility,regulation of cell proliferation,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to DNA damage stimulus,response to estradiol stimulus,response to estrogen stimulus,response to ionizing radiation,response to lipid,response to nutrient,ribonucleoprotein complex,ruffle,substrate adhesion-dependent cell spreading,transcription coactivator activity,transcription regulatory region DNA binding,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein ligase activity,zinc ion binding			0.09819	10.0794	A=256, T=19		A=34/222, T=18/1	2	
